CP-690550 (Tofacitinib) Citrate Mechanism of Action: JAK3 Inhibition in Lymphocyte Research

CP-690550 (Tofacitinib) Citrate MOA:Targeting JAK3/JAK-STAT Pathway for Rheumatoid Arthritis

🎯 check CP-690550 (Tofacitinib) Citrate product page

CP-690550 (Tofacitinib) Citrate is a potent JAK1 inhibitor. It affects JAK/STAT and IL-17A signaling by inhibiting JAK1 activation, effectively preventing high glucose- and IL-17A-mediated tight junction disruption and protecting blood-retinal barrier integrity.

Primary Applications and Mechanism of Action